SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-056951
Filing Date
2020-12-14
Accepted
2020-12-14 08:55:58
Documents
12
Period of Report
2020-12-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K srpt-8k_20201208.htm   iXBRL 8-K 36824
  Complete submission text file 0001564590-20-056951.txt   167046

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA srpt-20201208.xsd EX-101.SCH 5820
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE srpt-20201208_lab.xml EX-101.LAB 19493
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE srpt-20201208_pre.xml EX-101.PRE 11663
5 EXTRACTED XBRL INSTANCE DOCUMENT srpt-8k_20201208_htm.xml XML 3558
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 201385215
SIC: 2834 Pharmaceutical Preparations